The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 30th 2024
A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Metabolic Changes Accelerate Cognitive Decline in Type 2 Diabetics
March 3rd 2014Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.
Low Vitamin D Levels in Pregnancy Linked to Increased Gestational Diabetes Risk
February 27th 2014New study results suggest low levels of vitamin during the first trimester are a modest yet consistent and independent risk factor for developing gestational diabetes and are associated with insulin resistance at the second trimester.
Preventing the Spread of Vaccine-Preventable Disease Among Diabetic Patients
February 26th 2014While the dangers of influenza and pneumococcal pneumonia in patient with diabetes are well understood, less known is the fact that diabetics are at increased risk for contracting hepatitis B if they share blood glucose meters, finger stick devices, or other diabetes-care equipment.
Testosterone Levels Tied to Sildenafil's Success in Diabetics With Hypogonadism
February 24th 2014Similar to its effect in non-diabetic patients with low testosterone, sildenafil citrate correlates with improvements in testosterone levels and erectile function among hypogonadal men with type 2 diabetes mellitus.
Evaluating Treatments for Painful Diabetic Neuropathy
February 13th 2014Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.